Top Stocks
U.S. Stock Market Overview
Top Analyst Stocks
Top Smart Score Stocks
Top Insiders Stocks
Popular
Stock Screener
Top Online Growth Stocks
Trending Stocks
Penny Stock Screener
Dividend Investing
Dividend Calculator
Dividend Yield Calculator
Dividend Stocks
Dividend News
Dividend Calendar
ETFs
Top ETFs by AUM
SPY ETF
QQQ ETF
Stock Comparison
Energy Stocks
Oil Stocks
Best Value Stocks
Airline Stocks
Electric Vehicle Stocks
MATANA Stocks
New
Bank Stocks
Compare More Stocks…
Calendars
IPO Calendar
Earnings Calendar
Popular
Dividend Calendar
Economic Calendar
New
Market Holidays
Daily Analyst Ratings
Daily Insider Trading
Research Tools
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Stock Market News
Stock Analysis & Ideas
Popular
Global Markets News
Expert Spotlight
TipRanks Labs
Earnings Reports Insights
Pre-Market Breakdowns
Dividend Stock News
Crypto News
News
My Portfolio
My Performance
My Portfolio Analysis
Crowd Insights
My Watchlist
Smart Portfolio
About Us
About TipRanks
Contact Us
Working with TipRanks
Enterprise Solutions
Tools for Trading Platforms
Data for Hedge Funds
Best Online Brokers
Become an Affiliate
Follow Us
More
Plans
News
Smart Portfolio
Expert Center
Ideas
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
Top ETFs by AUM
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed Tools
Try Now
Top Stocks
Smart Score Stocks
Analysts' Hot Stocks
Insiders' Hot Stocks
Popular
Trending Stocks
Fastest Growing Websites
Hot
Penny Stocks
U.S. Markets
Market Movers
Top Experts
Expert Center
My Experts
Top Firms
Top Wall Street Analysts
Top Financial Bloggers
Top Corporate Insiders
Popular
Top Hedge Fund Managers
Top Individual Investors
Research Tools
Stock Screener
Stock Comparison
Dividend Calculator
Popular
Top ETFs by AUM
Dividend Yield Calculator
Daily Stock Ratings
Daily Insider Transactions
Comparisons
Stock Comparison
POPULAR COMPARISONS
Energy Stocks
EV Stocks
Crypto News
Dividend Stocks
Smart Portfolio
My Portfolio
My Performance
My Portfolio Analysis
Crowd Insights
Calendars
Earnings Calendar
Popular
Dividend Calendar
Economic Calendar
New
IPO Calendar
Stock Market Holidays
News
Market News
Stock Analysis & Ideas
Popular
Global Markets News
Expert Spotlight
Tipranks Labs
Earnings Reports Insights
Pre-Market Breakdowns
Dividend Stock News
Crypto News
About Us
About TipRanks
For Business
Become an Affiliate
Reviews
Contact Us
Plans & Pricing
PCRX
Stock Latest News
The Fly
Pacira price target lowered to $63 from $68 at Truist
10d ago
PCRX
The Fly
Pacira price target lowered to $52 from $60 at BMO Capital
22d ago
PCRX
The Fly
Pacira price target lowered to $63 from $66 at Needham
22d ago
PCRX
The Fly
Pacira sees FY22 EPS ‘at least’ $2.50, consensus $2.77
23d ago
PCRX
Press Releases
Pacira BioSciences Reports Preliminary Unaudited Total Revenue for 2022 of $666.8 Million
23d ago
PCRX
The Fly
Pacira price target lowered to $50 from $54 at Cowen
2M ago
PCRX
The Fly
Pacira sinks after continuing to not provide outlook with monthly sales
2M ago
PCRX
The Fly
Pacira reports preliminary net product sales of $57.5M for November
2M ago
PCRX
The Fly
Paulson adds Rumble, exits Occidental in Q3
2M ago
AU
NG
Press Releases
Pacira BioSciences Reports Preliminary Net Product Sales of $54.9 Million for October 2022
2M ago
PCRX
Press Releases
Pacira BioSciences to Present at Two Healthcare Conferences in November
3M ago
PCRX
The Fly
Pacira price target lowered to $60 from $66 at BMO Capital
3M ago
PCRX
Press Releases
Pacira BioSciences Announces Positive Topline Data from Phase 3 Study of EXPAREL as a Single-dose Sciatic Nerve Block in the Popliteal Fossa for Bunionectomy
4M ago
PCRX
Press Releases
Pacira Receives Positive CHMP Opinion for EXPAREL® for the Treatment of Postsurgical Pain in Children Aged 6 or Older
4M ago
PCRX
Press Releases
Pacira BioSciences Reports Preliminary Net Product Sales of $59.1 Million for August 2022
5M ago
PCRX
Press Releases
Pacira BioSciences Announces Positive Topline Data from Phase 3 Study of EXPAREL as a Single-dose Femoral Nerve Block in the Adductor Canal for Total Knee Arthroplasty
5M ago
PCRX
Press Releases
Pacira BioSciences Reports Preliminary Net Product Sales of $50.2 Million for July 2022
6M ago
PCRX
Press Releases
NFL Alumni Association and Pacira BioSciences Team Up to Educate Athletes and Communities About Non-Opioid Options to Manage Pain
6M ago
PCRX
Press Releases
Pacira BioSciences Reports Preliminary Second Quarter 2022 Revenue of $169.4 Million
7M ago
PCRX
Stock Analysis & Ideas
3 High-Growth Stocks Hitting Fresh 52-Week Highs
10M ago
AIZ
HDSN
Show More
You need to enable JavaScript to run this app.